Generate a tailored SOP for Dr. Howard Gurney. Improve your application with a focused, well-structured draft.
Professor Howard Gurney is the Director of Clinical Trials and the Head of the Cancer Program at Macquarie University Hospital. He is also a Senior Staff Specialist in Medical Oncology at Westmead Hospital. Professor Gurney has a robust background in clinical research, particularly specializing in urogenital cancers, including prostate, bladder, testis, and kidney cancer. He has served as the principal investigator for over 150 clinical trials and has published extensively, with more than 150 peer-reviewed articles focusing on genitourinary cancers and pharmacogenomics. His work has been featured in prestigious journals such as the New England Journal of Medicine and The Lancet Oncology. In addition to his research on urogenital cancers, he is well-versed in pharmacogenomics and therapeutic monitoring of chemotherapy and targeted therapies. Professor Gurney is recognized as an authority on the mechanisms of safe dosing for anticancer agents and has secured several research grants, contributing to critical discussions through numerous invited editorials. His research interests continue to evolve, addressing the complexities of cancer treatment and patient care in oncology.
Applied to Department of Business (MBA Program).